Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Andrea Groselj-Strele is active.

Publication


Featured researches published by Andrea Groselj-Strele.


Allergy | 2009

The basophil activation test in the diagnosis of allergy: technical issues and critical factors.

Gunter J. Sturm; Bettina Kranzelbinder; Eva M. Sturm; Akos Heinemann; Andrea Groselj-Strele; Werner Aberer

Background:  The basophil activation test (BAT) is a widely validated and reliable tool especially for the diagnosis of hymenoptera venom allergy. Nevertheless, several pitfalls have to be considered and outcomes may differ because of diverse in‐house protocols and commercially available kits. We aimed to identify the factors that may influence results of the CD63‐based BAT.


Cytometry Part B-clinical Cytometry | 2010

CD203c‐based basophil activation test in allergy diagnosis: Characteristics and differences to CD63 upregulation

Eva M. Sturm; Bettina Kranzelbinder; Akos Heinemann; Andrea Groselj-Strele; Werner Aberer; Gunter J. Sturm

The basophil activation test (BAT) based on CD203c upregulation has been validated as a reliable tool for the diagnosis of IgE‐mediated allergies. Nevertheless, CD203c‐based BAT is hardly comparable with that of CD63‐based tests, as the mechanisms of CD203c versus CD63 induction differ considerably. The aim of the present study was to identify potent influencing factors of the CD203c‐based BAT and to emphasize differences between CD63 and CD203c detection.


Allergy | 2007

Influence of total IgE levels on the severity of sting reactions in Hymenoptera venom allergy.

Gunter J. Sturm; Akos Heinemann; Christian Schuster; Michaela Wiednig; Andrea Groselj-Strele; Eva M. Sturm; Werner Aberer

Background:  Detection of specific IgE for Hymenoptera venoms and skin tests are well established diagnostic tools for the diagnosis of insect venom hypersensitivity. The aim of our study was to analyze the effect of total IgE levels on the outcome of generalized anaphylactic reactions after a Hymenoptera sting.


Journal of Voice | 2010

Sex hormones and the elderly male voice.

Markus Gugatschka; Karl Kiesler; Barbara Obermayer-Pietsch; Bernadette Schoekler; Christoph Schmid; Andrea Groselj-Strele; Gerhard Friedrich

The objective was to describe influences of sex hormones on the male voice in an elderly cohort. Sixty-three elderly males were recruited to undergo assessment of voice parameters, stroboscopy, voice-related questionnaires, a blood draw, and an ultrasound examination of the laryngeal skeleton. The group was divided into men with normal hormonal status and men with lowered levels of sex hormones, called hypogonades. Depending on the level of androgens, voice parameters did not differ. In subjects with decreased levels of estrogens, a significant increase in mean fundamental frequency, as well as changes of highest and lowest frequency plus a shift of the frequency range could be detected. We could detect significant changes of voice parameters depending on status of estrogens in elderly males. Androgens appear to have no impact on the elderly male voice. To our knowledge, this is the first prospective study that correlates sex hormones with voice parameters in elderly men.


Vox Sanguinis | 2010

Function and activation state of platelets in vitro depend on apheresis modality

Susanne Macher; S. Sipurzynski-Budraß; Konrad Rosskopf; E. Rohde; A. Griesbacher; Andrea Groselj-Strele; Gerhard Lanzer; Katharina Schallmoser

Background and Objectives  In multicomponent collection, various blood components are prepared during one apheresis process. The aim of this prospective crossover study was to compare the function, metabolic parameters and activation state of fresh and stored platelets (PLTs) collected by two different cell separators.


International Archives of Allergy and Immunology | 2009

Asymptomatic sensitization to hymenoptera venom is related to total immunoglobulin E levels.

Gunter J. Sturm; Christian Schuster; Bettina Kranzelbinder; Michaela Wiednig; Andrea Groselj-Strele; Werner Aberer

Background: The detection of specific serum immunoglobulin E (sIgE) to Hymenoptera venoms is an established diagnostic tool to diagnose insect venom hypersensitivity. However, the specificity of sIgE detection is a debated issue. Methods: In 145 subjects, total IgE (tIgE) and sIgE to Hymenoptera venoms as well as sIgE to rapeseed as a marker of cross-reactive carbohydrate determinants were measured. In addition, an atopy score was determined for each patient. We looked for a possible association between tIgE and the presence of sIgE in subjects with a negative history of large local or systemic reactions to insect stings. Results: Fifteen of 65 subjects (23.1%) with low levels of tIgE (<50 kU/l) had sIgE for bee or wasp venom, and 23 of 47 subjects (48.9%) with a tIgE from 50 to 250 kU/l showed sIgE. The highest rate of asymptomatic sensitization (22 of 33; 66.7%) was found in patients with tIgE levels higher than 250 kU/l. Median sIgE was approximately 4.8 times higher in subjects with tIgE levels above 250 kU/l than in those with tIgE levels <50 kU/l. Interestingly, a significant difference in median tIgE was recorded between individuals with and without sIgE to rapeseed [776.5 kU/l (25, 75% percentiles: 252.5, 2,000.0) vs. 50.5 kU/l (20.1, 172.0), respectively; p < 0001]. Conclusion: Specific antibodies are frequently seen in individuals with high tIgE, but appear to be largely irrelevant in clinical terms. This might lead to misdiagnosis in persons with an inconclusive sting history.


The Journal of Urology | 2012

Prognostic Value of the Leibovich Prognosis Score Supplemented by Vascular Invasion for Clear Cell Renal Cell Carcinoma

Martin Pichler; Georg C. Hutterer; Thomas F. Chromecki; Johanna Jesche; Andrea Groselj-Strele; Karin Kampel-Kettner; Karl Pummer; Richard Zigeuner

PURPOSE We assessed whether supplementing the Leibovich prognosis score with vascular invasion would improve prognostic value to predict metastatic disease in patients with nonmetastatic clear cell renal cell carcinoma. MATERIALS AND METHODS We retrospectively evaluated the pathology records of 1,754 patients with nonmetastatic clear cell renal cell carcinoma treated with surgery between 1984 and 2006 at a single tertiary academic center. The Leibovich prognosis score was supplemented by additional scoring for vascular invasion. Metastasis-free survival was assessed using the Kaplan-Meier method for each score category. A Cox regression model was used for multivariate testing. Predictive accuracy was determined by the Harrell concordance index and decision curve analysis. RESULTS Median followup was 84 months. Ten-year metastasis-free survival probability for a score of 0 to 1 and 2 to 8 or greater was 95%, 83%, 78%, 81%, 69%, 51%, 15% and 13%, respectively. The concordance index was 0.792 compared to 0.778 from our external validation of the Leibovich prognosis score using routine pathological findings (p <0.05). Decision curve analysis also favored the predictive ability of the novel model. CONCLUSIONS Adding vascular invasion improved the predictive accuracy of our validation data by 1.4% over that of the Leibovich prognosis score. Patients with a score of 7 or greater had a more than 85% probability of metastatic disease at 10 years. Thus, they could be considered candidates for adjuvant treatment trials.


Journal of diabetes science and technology | 2008

Evaluation of implementation of a fully automated algorithm (enhanced model predictive control) in an interacting infusion pump system for establishment of tight glycemic control in medical intensive care unit patients.

Roman Kulnik; Johannes Plank; Christoph Pachler; Malgorzata E. Wilinska; Andrea Groselj-Strele; Doris Röthlein; Matthias Wufka; Norman Kachel; Karl Heinz Smolle; Sabine Perl; Thomas R. Pieber; Roman Hovorka; Martin Ellmerer

Background: The objective of this study was to investigate the performance of a newly developed decision support system for the establishment of tight glycemic control in medical intensive care unit (ICU) patients for a period of 72 hours. Methods: This was a single-center, open, non-controlled feasibility trial including 10 mechanically ventilated ICU patients. The CS-1 decision support system (interacting infusion pumps with integrated enhanced model predictive control algorithm and user interface) was used to adjust the infusion rate of administered insulin to normalize blood glucose. Efficacy and safety were assessed by calculating the percentage of values within the target range (80–110 mg/dl), hyperglycemic index, mean glucose, and hypoglycemic episodes (<40 mg/dl). Results: The percentage of values in time in target was 47.0% (±13.0). The average blood glucose concentration and hyperglycemic index were 109 mg/dl (±13) and 10 mg/dl (±9), respectively. No hypoglycemic episode (<40 mg/dl) was detected. Eleven times (1.5% of all given advice) the nurses did not follow and, thus, overruled the advice of the CS-1 system. Several technical malfunctions of the device (repetitive error messages and missing data in the data log) due to communication problems between the new hardware components are shortcomings of the present version of the device. As a consequence of these technical failures of system integration, treatment had to be stopped ahead of schedule in three patients. Conclusions: Despite technical malfunctions, the performance of this prototype CS-1 decision support system was, from a clinical point of view, already effective in maintaining tight glycemic control. Accordingly, and with technical improvement required, the CS-1 system has the capacity to serve as a reliable tool for routine establishment of glycemic control in ICU patients.


European Archives of Oto-rhino-laryngology | 2011

Vitamin D status is associated with disease-free survival and overall survival time in patients with squamous cell carcinoma of the upper aerodigestive tract

Markus Gugatschka; Karl Kiesler; Barbara Obermayer-Pietsch; Andrea Groselj-Strele; Antonia Griesbacher; Gerhard Friedrich

Considerable clinical and experimental data suggest that vitamin D plays a role in pathogenesis and progression of cancer; nevertheless clinical data for head and neck squamous cell carcinoma (HNSCC) are not available. The aim of our study was to associate tumor and clinical characteristics with status of vitamin D [25-hydroxyvitamin D (25(OH)D)]. 88 patients with newly diagnosed squamous cell carcinoma of the head and neck were included in the study. A blood draw was taken at the time of diagnosis. The observation period lasted from 2006 until 2010. Results: When compared to a cohort from an epidemiological study, serum levels of 25(OH)D were significantly reduced in patients with HNSCC. We furthermore found disease-free survival, as well as overall survival times to be significantly associated with 25(OH)D levels. In conclusion, results from our study suggest an influence of vitamin D status on cancer incidence, as well as on mortality of HNSCC.


The Journal of Thoracic and Cardiovascular Surgery | 2009

The particle gel immunoassay as a rapid test to rule out heparin-induced thrombocytopenia?

Katharina Schallmoser; Camilla Drexler; Eva Rohde; Dirk Strunk; Andrea Groselj-Strele; Gerhard Lanzer; Simon Panzer

Heparin-induced thrombocytopenia (HIT) is a prothrombotic condition characterized by a platelet decrease of 50% or thrombosis with a temporal relationship of 1 to 2 weeks after the initiation of heparin. These surrogate markers are useful for the clinical assessment but are hardly applicable in multimorbid patients with clinical conditions that mimic HIT. Platelet activation assays (heparin-induced platelet activation [HIPA] and serotonin release assay) and platelet factor 4 (PF4)/polyanion enzyme-linked immunosorbent assay (ELISA) confirm HIT. HIPA and serotonin release assay are highly specific, but they are laborious and require selected donor platelets and extended experience. High titer immunoglobulin (Ig)G antibodies correlate with clinical HIT, but ELISA is also time-consuming. The alternative heparin/PF4-antigen particle gel immunoassay (PaGIA) is easy, provides results within 1 hour, and detects mainly IgG but also IgA/M antibodies. We evaluated the specificity and sensitivity of PaGIA in relation to HIPA and ELISA in 285 patients with an undetermined likelihood for HIT with the intention to validate it as a rapid assay to exclude HIT.

Collaboration


Dive into the Andrea Groselj-Strele's collaboration.

Top Co-Authors

Avatar
Top Co-Authors

Avatar

Gunter J. Sturm

Medical University of Graz

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Werner Aberer

Medical University of Graz

View shared research outputs
Top Co-Authors

Avatar

Akos Heinemann

Medical University of Graz

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Eva M. Sturm

Medical University of Graz

View shared research outputs
Top Co-Authors

Avatar

Georg C. Hutterer

Medical University of Graz

View shared research outputs
Top Co-Authors

Avatar

Johanna Jesche

Medical University of Graz

View shared research outputs
Top Co-Authors

Avatar
Researchain Logo
Decentralizing Knowledge